from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1284/canA

LFCtreatmentdescriptionclass of inhibitor

1.854

Amikacinug/mL Amikacintranslation

2.579

Cap5-10ug/mL Capreomycintranslation

2.877

Rox10-50 ug/mL Roxithromycintranslation

-0.045

SM2-5 ug/mL Streptomycintranslation

1.776

Tet5-10 ug/mL Tetracyclinetranslation

-0.788

Rif0.2-5ug/mL Rifampicintranscription

0.087

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.389

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.447

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.656

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.657

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.068

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.149

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.805

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.165

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.190

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.194

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.841

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.414

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.208

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.549

KCN5-20 ug/mL Potassium cyaniderespiration

0.806

NaN30.2-2 mM Sodium aziderespiration

2.285

Nigericin50 uM Nigericinrespiration

0.178

TRC10-150 ug/mL Triclosanrespiration

0.655

TRZ10-25 ug/mL Thioridazinerespiration

0.749

Valinomycin0.5-10 uM Valinomycinrespiration

0.262

ZnSO42 mM ZnSO4respiration

0.674

menadione6-10 ug/mL Menadionerespiration

-0.416

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.324

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.261

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.277

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.398

NRP_1Non-replicating persistence stage 1dosRassociated

-0.583

Amp0.2mg/mL AmpicillincellWall

-0.411

Cephalexin20-100 ug/mL CephalexincellWall

-0.010

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.361

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.480

EMB10-20 ug/mL EthambutolcellWall

-0.485

Eta12-40 ug/mL EthionamidecellWall

-0.844

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.673

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.303

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.353

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.095

BZA0.12 mg/mL BenzamidearomaticAmides

-0.115

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.380

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.444

H2O24 mM hydrogen peroxideDNAdamaging

0.500

Levo10 ug/mL LevofloxacinDNAdamaging

-0.446

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.669

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.154

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.318

UVUV-irradiationDNAdamaging

-0.179

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.332

Antimycin12.5-50 ug/mL Antimycin A?

-0.325

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.280

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.291

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.812

PA8240.2-2 ug/mL PA-824?

-0.344

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.957

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.440

Verapamil50 uM Verapamil?

-0.256

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.390

methoxatin10-20 ug/mL Methoxatin?